Personal information

Other IDs

Loop profile: 1586491

Countries

Switzerland

Activities

Collapse all

Education and qualifications (1)

Swiss Society of Interventional Psychiatry (SGIP-SSPI): Bern, CH

2021-09-20 to present | Certificate of proficiency in Interventional Psychiatry
Qualification
Source: Self-asserted source
Maxim Kuzin

Professional activities (2)

Schweizerische Gesellschaft für Arzneimittelsicherheit in der Psychiatrie (SGAMSP): Zürich, CH

2021-04-01 to present
Membership
Source: Self-asserted source
Maxim Kuzin

Arbeitsgruppe „Therapeutisches Drug Monitoring“ der AGNP : Würzburg, DE

2018 to present
Membership
Source: Self-asserted source
Maxim Kuzin

Works (29)

Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug Reactions

Therapeutic Drug Monitoring
2024-04 | Journal article
DOI: 10.1097/FTD.0000000000001183
Contributors: Maxim Kuzin; Ekkehard Haen; Nazar Kuzo; Katharina Endres; Christoph Hiemke; Michael Paulzen; Georgios Schoretsanitis
Source: check_circle
Crossref

Therapeutic drug monitoring in the opioid substitution treatment

Pharmacopsychiatry
2024-03 | Conference abstract
DOI: 10.1055/s-0044-1779565
Part of ISSN: 1439-0795
Contributors: M. Kuzin
Source: Self-asserted source
Maxim Kuzin

Letter to the editor: Clozapine plasma levels under co-medication with fluvoxamine during COVID-19 infection: A case report

Schizophrenia Research
2023-11 | Journal article
DOI: 10.1016/j.schres.2023.09.014
Contributors: Maxim Kuzin; Carla Boeglin; Georgios Schoretsanitis; Manjinder Pannu; Wolfram Kawohl; Franziskos Xepapadakos
Source: check_circle
Crossref

Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review

International Journal of Psychiatry in Clinical Practice
2023-11 | Journal article
DOI: 10.1080/13651501.2023.2231047
Contributors: Pierre Baumann; Philipp Bauknecht; Maxim Kuzin; Georgios Schoretsanitis
Source: check_circle
Crossref

Changes in Psychotropic Drug Blood Levels After SARS-CoV-2 Vaccination: A Two-Center Cohort Study

Therapeutic Drug Monitoring
2023-06-05 | Journal article
DOI: 10.1097/ftd.0000000000001118
Part of ISSN: 0163-4356
Contributors: Maxim Kuzin; Fabian Gardin; Markus Götschi; Franziskos Xepapadakos; Wolfram Kawohl; Erich Seifritz; Antje Trauzeddel; Michael Paulzen; Georgios Schoretsanitis
Source: Self-asserted source
Maxim Kuzin
grade
Preferred source (of 2)‎

Switching From Aripiprazole Tablets to Oral Suspension in a Patient With Roux-en-Y Gastric Bypass

Journal of Clinical Psychopharmacology
2023-05 | Journal article
DOI: 10.1097/jcp.0000000000001685
Part of ISSN: 1533-712X
Part of ISSN: 0271-0749
Contributors: Maxim Kuzin; Georgios Schoretsanitis; Fabian Gardin; Götschi Markus; Wolfram Kawohl; Franziskos Xepapadakos
Source: Self-asserted source
Maxim Kuzin
grade
Preferred source (of 2)‎

Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy

Frontiers in Psychiatry
2022-10-17 | Journal article
DOI: 10.3389/fpsyt.2022.972141
Part of ISSN: 1664-0640
Contributors: Luzie Eichentopf; Christoph Hiemke; Andreas Conca; Jan Engelmann; Manfred Gerlach; Ursula Havemann-Reinecke; Gudrun Hefner; Vincenzo Florio; Maxim Kuzin; Klaus Lieb et al.
Source: Self-asserted source
Maxim Kuzin

Bariatric surgery: impact on oral aripiprazole and fluoxetine bioavailability – A clinical case

3rd Symposium of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) and Deutsche Gesellschaft für Biologische Psychiatrie (DGBP)
2022-09-12 | Conference poster
Contributors: Maxim Kuzin; Georgios Schoretsanitis; Markus Götschi ; Fabian Gardin; Wolfram Kawohl; Franziskos Xepapadakos
Source: Self-asserted source
Maxim Kuzin

Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

XIVth Symposium of the Task Force Therapeutic Drug Monitoring of the AGNP
2022-05 | Conference poster
DOI: 10.1055/s-0042-1747647
Part of ISSN: 1439-0795
Contributors: L. Eichentopf; C. Hiemke; A. Conca; J. Engelmann; M. Gerlach; U. Havemann-Reinecke; G. Hefner; V. Florio; Maxim Kuzin; K. Lieb et al.
Source: Self-asserted source
Maxim Kuzin

P.0693 Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range

European Neuropsychopharmacology
2021-12 | Conference poster
DOI: 10.1016/j.euroneuro.2021.10.653
Part of ISSN: 0924-977X
Contributors: L. Eichentopf; C. Hiemke; G. Hefner; G. Schoretsanitis; Maxim Kuzin; G. Zernig; U. Havemann-Reinecke; M. Gerlach; A. Conca; G. Gründer et al.
Source: Self-asserted source
Maxim Kuzin

The role of cytochrome P450 enzyme genetic variants in cannabis hyperemesis syndrome—A case report

Basic & Clinical Pharmacology & Toxicology
2021-07 | Journal article
DOI: 10.1111/bcpt.13581
Contributors: Maxim Kuzin; Franziskos Xepapadakos; Isabel Scharrer; Marc Augsburger; Chin‐Bin Eap; Georgios Schoretsanitis
Source: check_circle
Crossref

Authors’ Reply to Suhas et al.: Comment on: “Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation”

Clinical Pharmacokinetics
2021-04-26 | Journal article
DOI: 10.1007/s40262-021-01022-0
Part of ISSN: 0312-5963
Part of ISSN: 1179-1926
Source: Self-asserted source
Maxim Kuzin

Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis

Journal of Psychopharmacology
2021-03 | Journal article
DOI: 10.1177/0269881120985166
Contributors: Maxim Kuzin; Ekkehard Haen; Christoph Hiemke; Benjamin Bochon; Karolina Bochon; Gerhard Gründer; Michael Paulzen; Georgios Schoretsanitis
Source: check_circle
Crossref

Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs

Therapeutic Drug Monitoring
2020-11-04 | Journal article
DOI: 10.1097/ftd.0000000000000830
Part of ISSN: 0163-4356
Source: Self-asserted source
Maxim Kuzin

Pharmacokinetic interactions between clozapine and sertraline in smokers and non‐smokers

Basic & Clinical Pharmacology & Toxicology
2020-10 | Journal article
DOI: 10.1111/bcpt.13421
Contributors: Maxim Kuzin; Georgios Schoretsanitis; Ekkehard Haen; Florian Ridders; Christoph Hiemke; Gerhard Gründer; Michael Paulzen
Source: check_circle
Crossref

The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine—A case report

Basic & Clinical Pharmacology & Toxicology
2020-10 | Journal article
DOI: 10.1111/bcpt.13428
Contributors: Maxim Kuzin; Isabel Scharrer; Daniele Nolan; Markus Baumgartner; Michael Paulzen; Georgios Schoretsanitis; Franziskos Xepapadakos
Source: check_circle
Crossref

Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation

Clinical Pharmacokinetics
2020-10-01 | Journal article
DOI: 10.1007/s40262-020-00944-5
Part of ISSN: 0312-5963
Part of ISSN: 1179-1926
Source: Self-asserted source
Maxim Kuzin

Changes in Clozapine Bioavailability in a Percutaneous Endoscopic Gastrostomy-Fed Patient With Treatment-Resistant Schizophrenia

Journal of Clinical Psychopharmacology
2020-05 | Journal article
DOI: 10.1097/jcp.0000000000001207
Part of ISSN: 0271-0749
Source: Self-asserted source
Maxim Kuzin

Patterns of clozapine pharmacokinetics in patient subgroups with different body mass index

The 2nd Symposium of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) and Deutsche Gesellschaft für Biologische Psychiatrie (DGBP)
2020-03 | Conference paper
DOI: 10.1055/s-0039-3403047
Source: Self-asserted source
Maxim Kuzin

The Effects of Co-prescription of Pantoprazole on the Clozapine Metabolism

Pharmacopsychiatry
2019-10-15 | Journal article
DOI: 10.1055/a-1021-8827
Part of ISSN: 0176-3679
Part of ISSN: 1439-0795
Source: Self-asserted source
Maxim Kuzin

The clinical relevance of the pharmacological interaction between clozapine and sertraline

The 1st Symposium of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) and Deutsche Gesellschaft für Biologische Psychiatrie (DGBP)
2019-02 | Conference paper
DOI: 10.1055/s-0039-1679178
Source: Self-asserted source
Maxim Kuzin

Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine

Clinical Pharmacokinetics
2018-06 | Journal article
DOI: 10.1007/s40262-017-0591-8
Part of ISSN: 0312-5963
Part of ISSN: 1179-1926
Source: Self-asserted source
Maxim Kuzin

Pregnancy exposure to quetiapine – Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood and obstetrical outcomes

Schizophrenia Research
2018-05 | Journal article
DOI: 10.1016/j.schres.2017.09.043
Part of ISSN: 0920-9964
Source: Self-asserted source
Maxim Kuzin

The effect of pharmacological interaction between a proton pump inhibitor pantoprazole and clozapine

XIIIth Symposium of the Task Force Therapeutic Drug Monitoring of the AGNP
2018-05 | Conference paper
DOI: 10.1055/s-0038-1649536
Source: Self-asserted source
Maxim Kuzin

Effects of Proton Pump Inhibitors (PPI) on the metabolism of Venlafaxine

Abstracts of the XIIth Symposium of the AGNP Task Force on Therapeutic Drug Monitoring in Psychiatry
2016-05-10 | Conference paper
DOI: 10.1055/s-0036-1582053
Part of ISSN: 0176-3679
Part of ISSN: 1439-0795
Source: Self-asserted source
Maxim Kuzin

Pharmacokinetic considerations of different dosing regimens in clozapine medicated patients

Abstracts of the XIIth Symposium of the AGNP Task Force on Therapeutic Drug Monitoring in Psychiatry
2016-05-10 | Conference paper
DOI: 10.1055/s-0036-1582042
Part of ISSN: 0176-3679
Part of ISSN: 1439-0795
Source: Self-asserted source
Maxim Kuzin

Effects of Proton Pump Inhibitors (PPI) on the serum concentrations of Venlafaxine

Abstracts of the 29th Symposium of the AGNP
2015-09-03 | Conference paper
DOI: 10.1055/s-0035-1557970
Part of ISSN: 0176-3679
Part of ISSN: 1439-0795
Source: Self-asserted source
Maxim Kuzin

Arzneimittelmetabolismus und Therapieversagen

DNP - Der Neurologe und Psychiater
2015-02 | Journal article
DOI: 10.1007/s15202-015-0581-3
Part of ISSN: 1616-2455
Part of ISSN: 2196-6427
Source: Self-asserted source
Maxim Kuzin

Pharmacokinetic interaction between valproic acid, meropenem and risperidone

Pharmacopsychiatry
2014-08-28 | Journal article
DOI: 10.1055/s-0034-1386841
Part of ISSN: 0176-3679
Part of ISSN: 1439-0795
Source: Self-asserted source
Maxim Kuzin

Peer review (3 reviews for 3 publications/grants)

Review activity for Journal of clinical medicine. (1)
Review activity for Journal of neural transmission. (1)
Review activity for NPJ schizophrenia. (1)
How many people are using ORCID?